Postmastectomy radiotherapy for all node positive patients: The case against

J.m. Dixon; I.h. Kunkler; N. Russell; C. Thomssen

doi:10.1016/j.ejso.2021.06.025

Postmastectomy radiotherapy for all node positive patients: The case against

J.m. Dixon, I.h. Kunkler^*, N. Russell, C. Thomssen

^*Corresponding author for this work

Deanery of Molecular, Genetic and Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.

We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.

Original language	English
Pages (from-to)	2515-2520
Number of pages	6
Journal	European Journal of Surgical Oncology (EJSO)
Volume	47
Issue number	10
DOIs	https://doi.org/10.1016/j.ejso.2021.06.025
Publication status	Published - 28 Jun 2021

Keywords / Materials (for Non-textual outputs)

postmastectomy radiotherapy
breast cancer

Access to Document

10.1016/j.ejso.2021.06.025

EJSO7.6.21.cleanifinal PMRT v8 with tables andfigure JMD
This is a pre-copyedited, author-produced version of an article accepted for publication in European Journal of Surgical Oncology following peer review. The version of record "Postmastectomy radiotherapy for all node positive patients: The case against" is available online at:DOI: 10.1016/j.ejso.2021.06.025
Accepted author manuscript, 0.99 MBLicence: CC BY-NC-ND

https://linkinghub.elsevier.com/retrieve/pii/S0748798321005898

Cite this

@article{dacbcb1182954c87a69c62a014825c70,

title = "Postmastectomy radiotherapy for all node positive patients: The case against",

abstract = "Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.",

keywords = "postmastectomy radiotherapy, breast cancer",

author = "J.m. Dixon and I.h. Kunkler and N. Russell and C. Thomssen",

year = "2021",

month = jun,

day = "28",

doi = "10.1016/j.ejso.2021.06.025",

language = "English",

volume = "47",

pages = "2515--2520",

journal = "European Journal of Surgical Oncology (EJSO)",

issn = "0748-7983",

publisher = "W.B. Saunders Company",

number = "10",

}

TY - JOUR

T1 - Postmastectomy radiotherapy for all node positive patients

T2 - The case against

AU - Dixon, J.m.

AU - Kunkler, I.h.

AU - Russell, N.

AU - Thomssen, C.

PY - 2021/6/28

Y1 - 2021/6/28

N2 - Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.

AB - Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.

KW - postmastectomy radiotherapy

KW - breast cancer

U2 - 10.1016/j.ejso.2021.06.025

DO - 10.1016/j.ejso.2021.06.025

M3 - Article

SN - 0748-7983

VL - 47

SP - 2515

EP - 2520

JO - European Journal of Surgical Oncology (EJSO)

JF - European Journal of Surgical Oncology (EJSO)

IS - 10

ER -

Postmastectomy radiotherapy for all node positive patients: The case against

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this